- When: January 24, 8:00am - 10:00am
- Where: Latham & Watkins LLP,140 Scott Dr.,
Menlo Park, CA 94025-1008 Map and Directions.
- Parking: Ample parking available at no cost in the employee lot.
- Attire: Business Attire Suggested
As big pharma faces increasing pressure on growth due to patent expirations and generics competition, biotech partnerships become even more critical because of the amount of cash already spent on partnerships and the lack of generics competition in biotech. As part of this breakfast session a panel of biotech and pharma executives will share their first hand experience in pharma-biotech partnerships, as well as share their insight into: when to partner, why partner, what companies should be looking for in a partnership, partnership pitfalls, short term vs. long term partnership goals.
Moderator:
Martin H. Goldstein, JD
Senior Vice President, Corporate Development, OncoMed Pharmaceuticals
Panel Speakers:
René Castro, PhD
Senior Director, Business Development, Exelixis Inc.
Christopher Dammann
Vice President, Business Development, Affymax, Inc.
Kinney Horn
Senior Manager, Business Development, Genentech
Yael Weiss, MD, PhD
Director, Licensing and External Research, Merck Research Laboratories Merck & Co., Inc.
THIS EVENT IS SOLD OUT
- Pre-registered attendees will receive an immediate receipt/confirmation after submission.
Please print this receipt/confirmation and bring it with you to receive your conference credentials.
Photo ID (driver's license or passport) will be required at check-in.
- All sales are final - BayBio offers no refunds.
Please mail your event-related questions to:
events@baybio.org or you can contact us via phone: 650-871-7101.
Is your company a member? Click
here to check.
See how your company can save money by becoming a BayBio member!
